TY - JOUR
T1 - TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations
AU - O'Rawe, Jason A.
AU - Wu, Yiyang
AU - Dörfel, Max J.
AU - Rope, Alan F.
AU - Au, P. Y.Billie
AU - Parboosingh, Jillian S.
AU - Moon, Sungjin
AU - Kousi, Maria
AU - Kosma, Konstantina
AU - Smith, Christopher S.
AU - Tzetis, Maria
AU - Schuette, Jane L.
AU - Hufnagel, Robert B.
AU - Prada, Carlos E.
AU - Martinez, Francisco
AU - Orellana, Carmen
AU - Crain, Jonathan
AU - Caro-Llopis, Alfonso
AU - Oltra, Silvestre
AU - Monfort, Sandra
AU - Jiménez-Barrón, Laura T.
AU - Swensen, Jeffrey
AU - Ellingwood, Sara
AU - Smith, Rosemarie
AU - Fang, Han
AU - Ospina, Sandra
AU - Stegmann, Sander
AU - Den Hollander, Nicolette
AU - Mittelman, David
AU - Highnam, Gareth
AU - Robison, Reid
AU - Yang, Edward
AU - Faivre, Laurence
AU - Roubertie, Agathe
AU - Rivière, Jean Baptiste
AU - Monaghan, Kristin G.
AU - Wang, Kai
AU - Davis, Erica Ellen
AU - Katsanis, Elias Nicholas
AU - Kalscheuer, Vera M.
AU - Wang, Edith H.
AU - Metcalfe, Kay
AU - Kleefstra, Tjitske
AU - Innes, A. Micheil
AU - Kitsiou-Tzeli, Sophia
AU - Rosello, Monica
AU - Keegan, Catherine E.
AU - Lyon, Gholson J.
N1 - Funding Information:
G.J.L. is supported by funds from the Stanley Institute for Cognitive Genomics at Cold Spring Harbor Laboratory. K.W. is supported by NIH grant HG006465. The sequencing by Complete Genomics was provided by a data-analysis grant to K.W. We would like to thank Megan Cho for facilitating discovery of affected individuals through GeneDx. Margaret Yoon and David Tegay assisted with Human Phenotype Ontology annotation. A.M.I. and J.S.P. were supported by a grant from the Alberta Children’s Hospital Foundation and would like to thank Francois Bernier and Ryan Lamont for helpful discussions and contributions. F.M., M.R., and colleagues are supported by grant PI14/00350 (Instituto de Salud Carlos III Acción Estratégica en Salud 2013–2016; Fondo Europeo de Desarrollo Regional). This work was supported in part by funding from grants from the Netherlands Organization for Health Research and Development, ZonMw (grant 907-00-365 to T.K.), and an institutional award from Cincinnati Children’s Hospital (R.B.H.). N.K. is a distinguished George W. Brumley Professor. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about .
Publisher Copyright:
© 2015 The Authors.
PY - 2015/12/3
Y1 - 2015/12/3
N2 - We describe an X-linked genetic syndrome associated with mutations in TAF1 and manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals. Simultaneous studies using diverse strategies led to the identification of nine families with overlapping clinical presentations and affected by de novo or maternally inherited single-nucleotide changes. Two additional families harboring large duplications involving TAF1 were also found to share phenotypic overlap with the probands harboring single-nucleotide changes, but they also demonstrated a severe neurodegeneration phenotype. Functional analysis with RNA-seq for one of the families suggested that the phenotype is associated with downregulation of a set of genes notably enriched with genes regulated by E-box proteins. In addition, knockdown and mutant studies of this gene in zebrafish have shown a quantifiable, albeit small, effect on a neuronal phenotype. Our results suggest that mutations in TAF1 play a critical role in the development of this X-linked ID syndrome.
AB - We describe an X-linked genetic syndrome associated with mutations in TAF1 and manifesting with global developmental delay, intellectual disability (ID), characteristic facial dysmorphology, generalized hypotonia, and variable neurologic features, all in male individuals. Simultaneous studies using diverse strategies led to the identification of nine families with overlapping clinical presentations and affected by de novo or maternally inherited single-nucleotide changes. Two additional families harboring large duplications involving TAF1 were also found to share phenotypic overlap with the probands harboring single-nucleotide changes, but they also demonstrated a severe neurodegeneration phenotype. Functional analysis with RNA-seq for one of the families suggested that the phenotype is associated with downregulation of a set of genes notably enriched with genes regulated by E-box proteins. In addition, knockdown and mutant studies of this gene in zebrafish have shown a quantifiable, albeit small, effect on a neuronal phenotype. Our results suggest that mutations in TAF1 play a critical role in the development of this X-linked ID syndrome.
KW - TAF1
KW - abnormal gait
KW - developmental delay
KW - dystonia
KW - facial dysmorphology
KW - intellectual disability
KW - intergluteal crease
KW - neurologic features
KW - transcription
UR - http://www.scopus.com/inward/record.url?scp=84951835643&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951835643&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2015.11.005
DO - 10.1016/j.ajhg.2015.11.005
M3 - Article
C2 - 26637982
AN - SCOPUS:84951835643
SN - 0002-9297
VL - 97
SP - 922
EP - 932
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 6
ER -